Historic cancer drug approval has roots at Johns Hopkins and its Bloomberg~Kimmel Institute laboratories and clinics
Breaking news today as, for the first time, a drug has been FDA-approved for cancer based on disease genetics rather than type. Developed from 30… Read More »Historic cancer drug approval has roots at Johns Hopkins and its Bloomberg~Kimmel Institute laboratories and clinics